Prescription Digital Therapeutics (PDTx) Market to Observe Prominent CAGR Growth of 20.35% by 2030
Global Prescription Digital Therapeutics (PDTx) Market report offers advanced information and scenario about the HELATH industry which helps to stand apart in the competition in this fast paced business environment. An influential market report gives methodical idea about the current scenario of the global market, recent developments, product launches, joint ventures, capacity, production value, mergers and acquisitions based on several market dynamics. The data of this report not only restrains the risks of ambiguity but also lend a hand in taking sound decisions while maintaining the reputation of the firm and its products. Global Prescription Digital Therapeutics (PDTx) Market research report explains everything in detail that serves the business purpose and gives a competitive advantage.
Prescription digital therapeutics (PDTx) encompass software-based treatments designed to address various illnesses. With the merging of technology and biology, prescription digital medications have emerged as a novel category of therapeutic tools. These innovative solutions leverage artificial intelligence, algorithms, and virtual reality to deliver direct treatments for critical disorders comparable to traditional biologics or medications. PDTx represents an exciting advancement at the intersection of healthcare and technology, revolutionizing the treatment landscape.
Data Bridge Market Research analyses that the prescription digital therapeutics (PDTx) market which is USD 3.90 billion in 2022, is expected to reach USD 17.16 billion by 2030, at a CAGR of 20.35% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-prescription-digital-therapeutics-dtx-market&shri
The acceptance of PDTx by providers, which in turn depends on payers’ willingness to fairly compensate physicians for digital medicines, is key to the success of PDTx. Only 40% of payers were expected to cover PDTx in 2021, according to a Pear Therapeutics and Avalere joint poll, and 50% of them planned to do so in the following 18 months. The main element would be PDTx’s clinical effectiveness in enhancing patient outcomes. It is reassuring for PDTx producers as they continue to innovate given the recent flurry of regulatory and FDA approvals for PDTx and the willingness of the majority of payers to fund PDTx reimbursements in the future.
Prescription digital therapeutics is a form of software-based therapeutics used to treat a wide range of illnesses. Technology and biology are combined to make prescription digital medications. These therapeutic tools were created using artificial intelligence, several algorithms, and virtual reality. Prescription PDTs, or digital therapeutics, are a brand-new medicinal category. PDTs act as direct treatments for critical disorders such as conventional biologics or medications.
The Prominent Key Players Operating in the Prescription Digital Therapeutics (PDTx) Market Include:
- ResMed (U.S.)
- SAMSUNGHEALTHCARE (South Korea)
- Biofourmis (US)
- Novartis AG (Switzerland)
- Medtronic (Ireland)
- Pear Therapeutics, Inc. (U.S.)
- Voluntis (France)
- Omada Health, Inc. (U.S.)
- GAIA AG (Germany)
- Welldoc’s Bluestar (U.S.)
- Solera Network (U.S.)
- Akili Interactive Labs, Inc. (U.S.)
- Better Therapeutics, LLC (U.S.)
- BigHealth (U.S.)
- Biofourmis (U.S.)
- Click Therapeutics, Inc. (U.S.)
- Happify, Inc. (U.S.)
- Limbix Health, Inc. (U.S.)
- Naturalcycles Nordic AB (Sweden)
- NuvoAir AB (Sweden)
- Sensyne Health plc. (U.K.)
- Xealth (U.S.)
Restraints/Challenges
- Privacy and security will hinder the market growth
Given the strict regulatory restrictions surrounding PHI (Personal Health Information) data, all parties participating in the manufacture and application of digital medicines must work to protect the confidentiality and security of the information gathered. To protect the privacy of patient data, for instance, manufacturers are required to abide by HIPAA (Health Insurance Portability and Accountability Act) rules. To ensure regulatory compliance of data flows, manufacturers must also cooperate with partners who are HITRUST- (Health Information Trust Alliance) certified. This delays the process which will derail the market growth rate.
This prescription digital therapeutics (PDTx) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the prescription digital therapeutics (PDTx) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2020, Reset prescription digital therapies have announced market approval from Singapore’s Health Science Authority for the treatment of people with substance use disorders, according to Pear Therapeutics, Inc.
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-prescription-digital-therapeutics-dtx-market?Shri
Prescription Digital Therapeutics (PDTx) Market Scope
The prescription digital therapeutics (PDTx) market is segmented on the basis of mechanism, category, treatment, software, services, app accessibility, app type, application and patients. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Mechanism
- Input Mechanisms
- Output Mechanisms
Category
- Medication Augmentation
- Medication Replacement
Treatment
- Outpatient Treatment
- Monotherapy
Software
- Software for Respiratory Conditions
- Software for Mental Health
- Software for Opioid Use Disorder
- Software for Diabetes
- Others
Services
- Behavioral Microservices
- Medical Microservices
App Accessibility
- Android
- iOS
- Windows
App Type
- Native Apps
- Web Apps
Application
- Substance Use Disorder (SUD)
- Opioid Use Disorder (OUD)
- Attention Deficit/Hyperactivity Disorder (ADHD)
- Alzheimer’s Disease
- Major Depressive Disorder (MDD)
- Insomnia
- Epilepsy
- Movement Disorder
- Multiple Sclerosis
- Migraine
- Autism Spectrum Disorder
- Oncology
- Inflammation
- Respiratory
- Cardiovascular
- Pain Management
- Metabolic Conditions
- Others
Patients
- Children
- Adults
Report Coverage:
• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.
• Comprehensive insights into regional developments.
• List of major industry players.
• Key strategies adopted by the market players.
• Latest industry developments include product launches, partnerships, mergers, and acquisitions.
This Market Intelligence Report Analyses Some of the Most Crucial Concerns:
- How will the major segments of this international market develop over the next few years?
- Who are the major players that will dominate the market in the future?
- When it comes to this industry, who are the top suppliers and producers?
- How have the most successful companies in the industry planned for future growth and expansion?
- In what sectors might we expect to see the greatest increase in demand over the coming years?
- How many distinct subsets of buyers make up this market?
- Which regional powerhouse do you foresee as becoming the largest player in the international market?
- Does a new coronavirus pandemic have any consequences?
- In what ways are established actors stymied by the entry of newcomers, and how may they be overcome?
Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-prescription-digital-therapeutics-dtx-market&shri
Prescription Digital Therapeutics (PDTx) Market Regional Analysis/Insights
The prescription digital therapeutics (PDTx) market is analysed and market size insights and trends are provided by country, mechanism, category, treatment, software, services, app accessibility, app type, application and patients as referenced above.
The countries covered in the prescription digital therapeutics (PDTx) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the prescription digital therapeutics (PDTx) market due to increased research and development being done on prescription digital therapeutics (PDTx) and rising healthcare spending. The expansion of the main companies and the entrance of new start-ups will also accelerate the market’s growth rate in this area.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to rising healthcare costs and the region’s growing prevalence of chronic diseases. Additionally, improvements in the system for paying for digital therapies may speed up the market’s expansion in this area.
Investing in this study would grant you access to valuable information, including:
- Comprehensive coverage of the Industry, both globally and broken down by region.
- Regional-level breakdowns of the market, including North America, Europe, Asia Pacific, South America, and the Middle East & Africa.
- Country-specific market size splits for the most important countries with major market shares.
- Market share and revenue/sales data for the industry’s leading players.
- Analysis of market trends such as emerging technologies, products, and start-ups, as well as PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, and more.
- Detailed market size data, including breakdowns by application/industry verticals.
- Projections and forecasts for the market’s future growth and development.
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
